Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.36 USD | +0.43% | +4.20% | +88.81% |
Apr. 16 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |
Apr. 16 | Lexaria Bioscience Corp. Receives Ethics Review Board Approval to Begin New GLP-1 Study | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+88.81% | 30.28M | |
+26.02% | 661B | |
+26.69% | 566B | |
-6.65% | 352B | |
+20.39% | 332B | |
+2.51% | 283B | |
+13.49% | 231B | |
+4.80% | 200B | |
-9.28% | 195B | |
-5.39% | 145B |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Lexaria Bioscience Granted Two Canadian Patents for Nicotine Addiction Treatment Candidate